Nanomaterial-Based Drug Delivery Systems Therapeutic and Theranostic Applications /
Effective drug delivery systems are essential in maximizing the therapeutic effects of the drugs in question. This book thoroughly analyses recent technological advances in new, nanomaterial-based drug delivery systems for the diagnosis and treatment of various diseases. These systems also have dive...
保存先:
| 団体著者: | |
|---|---|
| その他の著者: | |
| フォーマット: | 電子媒体 eBook |
| 言語: | 英語 |
| 出版事項: |
Cham :
Springer International Publishing : Imprint: Springer,
2023.
|
| 版: | 1st ed. 2023. |
| 主題: | |
| オンライン・アクセス: | https://doi.org/10.1007/978-3-031-30529-0 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|
MARC
| LEADER | 00000nam a22000005i 4500 | ||
|---|---|---|---|
| 001 | 978-3-031-30529-0 | ||
| 003 | DE-He213 | ||
| 005 | 20260810170922.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 230621s2023 sz | o |||| 0|eng d | ||
| 020 | |a 9783031305290 |9 978-3-031-30529-0 | ||
| 024 | 7 | |a 10.1007/978-3-031-30529-0 |2 doi | |
| 050 | 4 | |a RS400-431 | |
| 072 | 7 | |a PSB |2 bicssc | |
| 072 | 7 | |a SCI013040 |2 bisacsh | |
| 072 | 7 | |a PNB |2 thema | |
| 082 | 0 | 4 | |a 615.19 |2 23 |
| 245 | 1 | 0 | |a Nanomaterial-Based Drug Delivery Systems |h [electronic resource] : |b Therapeutic and Theranostic Applications / |c edited by Chandrakantsing V. Pardeshi. |
| 250 | |a 1st ed. 2023. | ||
| 264 | 1 | |a Cham : |b Springer International Publishing : |b Imprint: Springer, |c 2023. | |
| 300 | |a 1 online resource (XII, 409 p. 100 illus.). |b 97 illus. in color. | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 341 | 0 | |b Table of contents navigation |2 onix | |
| 341 | 0 | |b Single logical reading order |2 onix | |
| 341 | 0 | |b Short alternative textual descriptions |2 onix | |
| 341 | 0 | |b Use of color is not sole means of conveying information |2 onix | |
| 341 | 0 | |b Use of high contrast between text and background color |2 onix | |
| 341 | 0 | |b Next / Previous structural navigation |2 onix | |
| 341 | 0 | |b All non-decorative content supports reading without sight |2 onix | |
| 347 | |a text file |b PDF |2 rda | ||
| 505 | 0 | |a Section-I: Introduction to nanomaterials for drug delivery -- Introduction to Nanomaterials for drug delivery -- Section-II: Nanomaterials-based drug delivery systems for Therapeutic applications -- Polymer-based nanomaterials -- Lipid-based nanomaterials -- Vesicular nanomaterials -- Hybrid nanomaterials -- Section-III: Nanomaterials-based drug delivery systems for Theranostic applications -- Magnetic nanoparticles -- Quantum dots -- Upconversion nanoparticles -- Gold nanoparticles -- Carbon-based nanoparticles -- Graphene-based nanoparticles -- Section-IV: Nanomaterials toxicity & clinical translation -- Nanotoxicology: an overview -- Patenting nanomaterials: Regulatory aspects -- Clinical perspectives: Translating nanomaterials from laboratory to clinic. | |
| 520 | |a Effective drug delivery systems are essential in maximizing the therapeutic effects of the drugs in question. This book thoroughly analyses recent technological advances in new, nanomaterial-based drug delivery systems for the diagnosis and treatment of various diseases. These systems also have diverse applications in pharmaceutical, biomedical, biomaterial, and biotechnological fields. This book explains the different types of nanocarriers currently in development and covers both therapeutic and theranostic applications of drug-loaded nanocarriers and nanomedicine. Clinical research professionals, industrial pharmaceutical scientists, and veteran drug delivery developers benefit from the unique structure of this book, making it essential for the drug delivery researcher. Students, research scholars, and industrial professionals alike benefit from the current technological advancements, regulatory aspects, and the history of discovery and development in the field of nanomedicine presented in this book. | ||
| 532 | 8 | |a Accessibility summary: This PDF does not fully comply with PDF/UA standards, but does feature limited screen reader support, described non-text content (images, graphs), bookmarks for easy navigation and searchable, selectable text. Users of assistive technologies may experience difficulty navigating or interpreting content in this document. We recognize the importance of accessibility, and we welcome queries about accessibility for any of our products. If you have a question or an access need, please get in touch with us at accessibilitysupport@springernature.com. | |
| 532 | 8 | |a No reading system accessibility options actively disabled | |
| 532 | 8 | |a Publisher contact for further accessibility information: accessibilitysupport@springernature.com | |
| 588 | |a Print version record. | ||
| 650 | 0 | |a Pharmaceutical chemistry. | |
| 650 | 0 | |a Nanomedicine. | |
| 650 | 0 | |a Toxicology. | |
| 650 | 0 | |a Pharmacology. | |
| 650 | 1 | 4 | |a Pharmaceutics. |
| 650 | 2 | 4 | |a Nanomedicine and Nanotoxicology. |
| 650 | 2 | 4 | |a Toxicology. |
| 650 | 2 | 4 | |a Pharmacology. |
| 650 | 2 | 4 | |a Medical Toxicology. |
| 700 | 1 | |a Pardeshi, Chandrakantsing V. |e editor. |4 edt |4 http://id.loc.gov/vocabulary/relators/edt | |
| 710 | 2 | |a SpringerLink (Online service) | |
| 773 | 0 | |t Springer Nature eBook | |
| 776 | 0 | 8 | |i Printed edition: |z 9783031305283 |
| 776 | 0 | 8 | |i Printed edition: |z 9783031305306 |
| 776 | 0 | 8 | |i Printed edition: |z 9783031305313 |
| 856 | 4 | 0 | |u https://doi.org/10.1007/978-3-031-30529-0 |
| 912 | |a ZDB-2-SBL | ||
| 912 | |a ZDB-2-SXB | ||
| 950 | |a Biomedical and Life Sciences (SpringerNature-11642) | ||
| 950 | |a Biomedical and Life Sciences (R0) (SpringerNature-43708) | ||